Dr. Reddys Laboratories informs about disclosure

22 Feb 2020 Evaluate

Further to intimations dated August 20, 2019 and February 16, 2020 with regard to the audit of Formulations Manufacturing Plant (Vizag SEZ Plant I - PTO 7) at Duvvada, Visakhapatnam, Dr. Reddys Laboratories has informed that the Company received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1208.45 -15.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×